logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumab/pembrolizumabNeuromuscular disorders/pneumonitis: 3 case reports

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2021年 / 1851卷 / 1期
关键词:
D O I:
10.1007/s40278-021-94285-1
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:195 / 195
相关论文
共 50 条
  • [41] Ipilimumab/nivolumab/pembrolizumabSarcoidosis: 2 case reports
    Reactions Weekly, 2017, 1676 (1) : 176 - 176
  • [42] Ipilimumab/nivolumab/pembrolizumabCardiotoxicity: 8 case reports
    Reactions Weekly, 2017, 1638 (1) : 129 - 130
  • [43] Ipilimumab/nivolumab/sasanlimabPolyarthritis: 2 case reports
    Reactions Weekly, 2023, 1938 (1) : 766 - 766
  • [44] Ipilimumab/nivolumab/pembrolizumabColitis: 2 case reports
    Reactions Weekly, 2020, 1808 (1) : 161 - 161
  • [45] Ipilimumab/nivolumab/pembrolizumabPneumonitis: 4 case reports
    Reactions Weekly, 2020, 1794 (1) : 131 - 131
  • [46] Ipilimumab/nivolumab/pembrolizumabArthralgia: 11 case reports
    Reactions Weekly, 2020, 1794 (1) : 130 - 130
  • [47] Ipilimumab/nivolumab/pembrolizumabEncephalitis: 4 case reports
    Reactions Weekly, 2021, 1868 (1) : 227 - 227
  • [48] Ipilimumab/nivolumab/pembrolizumabEncephalitis: 5 case reports
    Reactions Weekly, 2019, 1784 (1) : 157 - 157
  • [49] Ipilimumab/nivolumab/paclitaxelNeuropathy: 2 case reports
    Reactions Weekly, 2021, 1841 (1) : 132 - 132
  • [50] Ipilimumab/nivolumab/pembrolizumabColitis: 6 case reports
    Reactions Weekly, 2022, 1909 (1) : 301 - 301
← 12345 →